July 2026
1. PHILIPS CA, Oommen TT, Tharakan A
   Conclusions in search of a confirmatory analysis: the evidence does not yet justify routine proton pump inhibitors after endoscopic variceal ligation.
   Gut. 2026 Jul 14:gutjnl-2026-339166. doi: 10.1136/gutjnl-2026-339166.
   

   >> Share

   
   June 2026
2. HAN X, Xu HM, Liu ZC, Zhang L, et al
   Helicobacter pylori infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials.
   Gut. 2026 Jun 30:gutjnl-2026-338156. doi: 10.1136/gutjnl-2026-338156.
   

   >> Share

   
   April 2026
3. YADAV A, Mandavdhare HS, Sharma V, Saroch A, et al
   Proton pump inhibitors should be continued after endoscopic variceal ligation.
   Gut. 2026 Apr 14:gutjnl-2026-338098. doi: 10.1136/gutjnl-2026-338098.
   

   >> Share

   
   March 2026
4. LIU YH, Wu IT, Tsai TJ, Hsu PI, et al
   Optimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in Helicobacter pylori.
   Gut. 2026 Mar 6:gutjnl-2026-338544. doi: 10.1136/gutjnl-2026-338544.
   

   >> Share

   
   
5. YU B, Zhao F, Peppelenbosch MP, Li J, et al
   Limitations of Helicobacter pylori single-method testing: evidence from a cohort study.
   Gut. 2026 Mar 2:gutjnl-2025-337818. doi: 10.1136/gutjnl-2025-337818.
   

   >> Share

   
   January 2026
6. COLLATUZZO G, Camargo MC, Malvezzi M, Dajti E, et al
   Gastric cancer attributable to Helicobacter pylori in 2040.
   Gut. 2026 Jan 28:gutjnl-2025-337499. doi: 10.1136/gutjnl-2025-337499.
   

   >> Share

   
   
7. ZHENG B, Kobayashi H, Tu R, Huang K, et al
   Gastrin-dependent expansion of Cck2r(+) corpus progenitors accelerates ulcer healing and inhibits gastric dysplasia.
   Gut. 2026;75:265-277.
   

   >> Share

   
   December 2025
8. NOH Y, Choi A, Lee H, Yon DK, et al
   Proton pump inhibitors use and risk of inflammatory bowel disease in children.
   Gut. 2025 Dec 31:gutjnl-2025-337345. doi: 10.1136/gutjnl-2025-337345.
   

   >> Share

   
   November 2025
9. NIGAM GB, Oakland K, Hearnshaw S, Grasnt-Casey J, et al
   Acute upper gastrointestinal bleeding in the UK: 2022 audit update.
   Gut. 2025 Nov 19:gutjnl-2025-335134. doi: 10.1136/gutjnl-2025-335134.
   

   >> Share

   
   
10. WANG Y, Lu C, Liang Z, Weng D, et al
    Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding?
    Gut. 2025 Nov 17:gutjnl-2025-337421. doi: 10.1136/gutjnl-2025-337421.
    

    >> Share

    
    October 2025
11. LEUNG WK, Ang TL, Shah S, Cheung KS, et al
    Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions.
    Gut. 2025 Oct 7:gutjnl-2025-335823. doi: 10.1136/gutjnl-2025-335823.
    

    >> Share

    
    September 2025
12. LIOU JM, Malfertheiner P, Hong TC, Cheng HC, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.
    Gut. 2025 Sep 5:gutjnl-2025-336027. doi: 10.1136/gutjnl-2025-336027.
    

    >> Share

    
    July 2025
13. SCHULZ C, Liou JM, Alboraie M, Bornschein J, et al
    Helicobacter pylori antibiotic resistance: a global challenge in search of solutions.
    Gut. 2025 Jul 11:gutjnl-2025-335523. doi: 10.1136/gutjnl-2025-335523.
    

    >> Share

    
    June 2025
14. GONG R, Huang B, Ralser A, Friedrich V, et al
    CagA-dependent Hobit(+) gastric tissue-resident memory T cells confer full protection from Helicobacter pylori reinfection.
    Gut. 2025 Jun 5:gutjnl-2025-334781. doi: 10.1136/gutjnl-2025-334781.
    

    >> Share

    
    May 2025
15. SHIN J, Cha B, Hong J, Kwon KS, et al
    Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial.
    Gut. 2025 May 13:gutjnl-2024-332459. doi: 10.1136/gutjnl-2024-332459.
    

    >> Share

    
    April 2025
16. LEE YC
    Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
    Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
    

    >> Share

    
    October 2024
17. OLMEDO L, Calvet X, Gene E, Bordin DS, et al
    Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
    Gut. 2024 Oct 26:gutjnl-2024-332804. doi: 10.1136/gutjnl-2024-332804.
    

    >> Share

    
    August 2024
18. LIU Z, Hong J, He F
    Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2024 Aug 29:gutjnl-2024-333604. doi: 10.1136/gutjnl-2024-333604.
    

    >> Share

    
    July 2024
19. ZHANG Q, Dunbar KB, Odze RD, Agoston AT, et al
    Hypoxia-inducible factor-1alpha mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.
    Gut. 2024;73:1269-1279.
    

    >> Share

    
    June 2024
20. GAO W, Liu J, Wang X, Li J, et al
    Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy.
    Gut. 2024 Jun 21:gutjnl-2024-332640. doi: 10.1136/gutjnl-2024-332640.
    

    >> Share

    
    May 2024
21. YUAN S, Larsson SC, Gill D, Burgess S, et al
    Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis.
    Gut. 2024 May 2:gutjnl-2024-332280. doi: 10.1136/gutjnl-2024-332280.
    

    >> Share

    
    April 2024
22. DUTTA AK, Sharma V, Jain A, Elhence A, et al
    Inappropriate use of proton pump inhibitors in clinical practice globally: a systematic review and meta-analysis.
    Gut. 2024 Apr 26:gutjnl-2024-332154. doi: 10.1136/gutjnl-2024-332154.
    

    >> Share

    
    March 2024
23. BOECKXSTAENS G, Elsen S, Belmans A, Annese V, et al
    10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy.
    Gut. 2024;73:582-589.
    

    >> Share

    
    February 2024
24. AN H, Zhong M, Gan H
    Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.
    Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904.
    

    >> Share

    
    January 2024
25. XIAO X, Zhang X, Wang J, Liu Y, et al
    Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Gut. 2024 Jan 24:gutjnl-2023-330883. doi: 10.1136/gutjnl-2023-330883.
    

    >> Share

    
    
26. BLACK CJ, Paine PA, Ford AC
    Letter to the editor: Helicobacter pylori eradication, the proof is not in the symptoms-authors' reply.
    Gut. 2024 Jan 12:gutjnl-2024-331892. doi: 10.1136/gutjnl-2024-331892.
    

    >> Share

    
    December 2023
27. NARENDREN A, Tsoi AH, Iqbal A, Glance S, et al
    Rare complication of peptic ulcer disease.
    Gut. 2023 Dec 12:gutjnl-2023-330867. doi: 10.1136/gutjnl-2023-330867.
    

    >> Share

    
    
28. TOH DE, Lo SW, Tsoi A, Segal JP, et al
    Right tool for the right bleeder.
    Gut. 2023;73:206-207.
    

    >> Share

    
    November 2023
29. ZHU J, Sun C, Li M, Hu G, et al
    Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Gut. 2023 Nov 22:gutjnl-2023-330168. doi: 10.1136/gutjnl-2023-330168.
    

    >> Share

    
    
30. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    

    >> Share

    
    September 2023
31. LIU BD, Udemba SC, Liang K, Tarabichi Y, et al
    Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort st
    Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651.
    

    >> Share

    
    July 2023
32. 
    Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259.
    

    >> Share

    
    June 2023
33. SJOMINA O, Vangravs R, Leonova E, Polaka I, et al
    Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
    Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792.
    

    >> Share

    
    May 2023
34. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    

    >> Share

    
    
35. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    

    >> Share

    
    April 2023
36. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    

    >> Share

    
    
37. YE BD
    Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
    Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506.
    

    >> Share

    
    March 2023
38. CHEN PY, Tsai FP, Chen MJ, Yang HY, et al
    Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials.
    Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826.
    

    >> Share

    
    
39. ZHANG J, Deng Y, Liu C, Wang H, et al
    'Family-based' strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat' strategy.
    Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696.
    

    >> Share

    
    
40. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point.
    Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share